Inhibition of Aβ42 aggregation using peptides selected from combinatorial libraries
Authors:
- 26 June 2009
- journal article
- research article
- Published by Wiley in Journal of Peptide Science
- Vol. 15 (8) , 499-503
Abstract
Increasing evidence suggests that the aggregation of the small peptide Aβ42 plays an important role in the development of Alzheimer's disease. Inhibiting the initial aggregation of Aβ42 may be an effective treatment for preventing, or slowing, the onset of the disease. Using an in vivo screen based on the enzyme EGFP, we have searched through two combinatorially diverse peptide libraries to identify peptides capable of inhibiting Aβ42 aggregation. From this initial screen, three candidate peptides were selected and characterized. ThT studies indicated that the selected peptides were capable of inhibiting amyloid aggregation. Additional ThT studies showed that one of the selected peptides was capable of disaggregating preformed Aβ42 fibers. Copyright © 2009 European Peptide Society and John Wiley & Sons, Ltd.Keywords
Funding Information
- Seaver College of Science and Engineering
- NIH (R15AG032582)
This publication has 36 references indexed in Scilit:
- Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomersProtein Engineering, Design and Selection, 2008
- A High-Throughput Screen for Compounds That Inhibit Aggregation of the Alzheimer’s PeptideACS Chemical Biology, 2006
- Inhibitors of Amyloid Toxicity Based on β-sheet Packing of Aβ40 and Aβ42Biochemistry, 2006
- Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition MechanismChemical Biology & Drug Design, 2005
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- Mutations that Reduce Aggregation of the Alzheimer's Aβ42 Peptide: an Unbiased Search for the Sequence Determinants of Aβ AmyloidogenesisJournal of Molecular Biology, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001
- Selective Inhibition of Aβ Fibril FormationJournal of Biological Chemistry, 1996
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993